Applications and advancements of CRISPR-Cas in the treatment of lung cancer
Pan Lei, Yixin Ju, Fenfen Peng, Jie Luo · 2023
Read Applications and advancements of CRISPR-Cas in the treatment of lung cancer by Pan Lei, Yixin Ju, Fenfen Peng, Jie Luo (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10768725.txt.
Description
Pan Lei and co-authors review, in a 2023 paper, how the CRISPR gene editing system is being applied to lung cancer, from finding the disease to fighting its drug resistance. Lung cancer kills more people than most cancers, largely because it is caught late and therapies fail. A tool that cuts DNA at chosen spots changes both research and treatment design.
The review covers three fronts. For diagnosis, editing based tests can flag cancer signals. For target discovery, genome wide screens knock out genes one by one to find the ones tumors depend on. For therapy, editing attacks resistance pathways and engineers immune cells. The authors also survey the animal models built with the system, and the delivery problem: getting editors into lung tumors safely. Delivery, more than cutting power, is the bottleneck between this toolbox and the clinic.
Catalog record
| CREATOR | Pan Lei, Yixin Ju, Fenfen Peng, Jie Luo |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |